Presentation THT 2025 Subcutaneously Implanted Sensor for Remote Monitoring of Congestive Heart Failure Enables Effortless Capture of Electrocardiography and Three-Axis Acceleration Traces (ECG/SCG) Before and After Hospitalization: First Trend Results in Patients Presenter: Marat Fudim February 13, 2025
Presentation THT 2025 Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification Presenter: Kivanc Ozonat February 12, 2025
Presentation THT 2025 Impact of Prior Heart Failure Hospitalizations on Long-Term Outcomes Following ICD Implantation and Generator Exchange Presenter: Midori Torpoco Rivera February 12, 2025
Presentation THT 2025 Initial Diuretic Strategies and Heart Failure Hospitalization Outcomes: Insights From a Nationwide Community-Based Cohort Presenter: Anubodh Varshney February 12, 2025
Presentation THT 2025 Pulmonary Artery Diastolic Pressure Is Lower in Women Than Men Preceding and at the Time of Heart Failure Hospitalization Presenter: JoAnn Lindenfeld February 12, 2025
Presentation THT Abstracts 2025 Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification Presenter: Kivanc Ozonat February 11, 2025
Presentation TCT 2024 TCT 625: A Lower Ratio of Regurgitant Volume to Left Atrium Volume Is Associated With a Higher Incidence of Heart Failure Hospitalization in Patients With Ventricular Functional Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair Presenter: Masafumi Yoshikawa October 28, 2024
Presentation THT 2024 Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure Presenter: Liviu Klein March 05, 2024
Presentation THT 2024 Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization Presenter: Gad Cotter March 04, 2024
Presentation THT 2023 Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life? Presenter: Michael Sutherland March 21, 2023
Presentation THT 2023 Cardiovascular Hospitalization Rates in ATTR-CA: What Factors Make a Difference Presenter: Margaret Cuomo March 21, 2023
Presentation THT 2023 What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design Presenter: William Abraham March 20, 2023
Presentation THT 2022 Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial Presenter: Akshay Desai February 02, 2022
Presentation THT 2022 SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients Presenter: Shashank Sinha February 02, 2022
Presentation THT 2022 The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis Presenter: Mohammed Al-Sadawi February 01, 2022
Presentation ACC 2021 Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction Presenter: Adam DeVore May 17, 2021